Sirt-1 is required for the inhibition of apoptosis and inflammatory responses in human tenocytes

Journal of Biological Chemistry

Volumn 287, Issue 31, 2012, Pages 25770-25781

  Busch, Franziska ^a   Mobasheri, Ali ^b   Shayan, Parviz ^c   Stahlmann, Ralf ^d   Shakibaei, Mehdi ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Investigating Institute of Molecular Biological System Transfer   (Iran)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AKT ACTIVATION; ANTISENSE OLIGONUCLEOTIDES; APOPTOTIC SIGNALING; CASPASE-3; CATABOLIC PROCESS; CYCLOOXYGENASE 2; DEACETYLASE; DEACETYLATION; DESTRUCTIVE PROCESS; DOWN-REGULATION; GENE PRODUCTS; HISTONE DEACETYLASES; INFLAMMATORY RESPONSE; INHIBITORY EFFECT; INTERLEUKIN-1; MATRIX METALLOPROTEINASE-9; MOLECULAR MECHANISM; NICOTINAMIDE ADENINE DINUCLEOTIDES; OVERUSE INJURY; POLY POLYMERASE; RESVERATROL; TRANSCRIPTIONAL SILENCING; TRANSIENT TRANSFECTION; TUMOR SUPPRESSORS; UP-REGULATION;

ACETYLATION; ACTIVATION ANALYSIS; AMIDES; CHEMICAL ACTIVATION; DEGRADATION; ENZYMES; GENES; INTERFERENCE SUPPRESSION; PATHOLOGY; PROTEINS; TENDONS;

CELL DEATH;

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; CELL PROTEIN; CYCLOOXYGENASE 2; GELATINASE B; HISTONE DEACETYLASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN KINASE B; PROTEIN P53; RESVERATROL; SCLERAXIS; SIRTUIN 1; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CELLS; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; DOWN REGULATION; ENZYME INACTIVATION; GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INFLAMMATION; MATRIX METALLOPROTEINASE 9 GENE; MITOCHONDRIAL RESPIRATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TENOCYTE; UPREGULATION;

ACETYLATION; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME ACTIVATORS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-1BETA; MITOCHONDRIA; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; STILBENES; TENDINOPATHY; TENDONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84864390256     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.355420     Document Type: Article

References (55)

1. Favata, M., Beredjiklian, P. K., Zgonis, M. H., Beason, D. P., Crombleholme, T. M., Jawad, A. F., and Soslowsky, L. J. (2006) Regenerative properties of fetal sheep tendon are not adversely affected by transplantation into an adult environment. J. Orthop. Res. 24, 2124-2132 (Pubitemid 44717975)
2. Anitua, E., Andía, I., Sanchez, M., Azofra, J., del Mar Zalduendo, M., de la Fuente, M., Nurden, P., and Nurden, A. T. (2005) Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J. Orthop. Res. 23, 281-286 (Pubitemid 40287850)
3. Järvinen, T. A., Kannus, P., Maffulli, N., and Khan, K. M. (2005) Achilles tendon disorders. Etiology and epidemiology. Foot Ankle Clin. 10, 255-266 (Pubitemid 40732785)
4. Lian, O. B., Engebretsen, L., and Bahr, R. (2005) Prevalence of jumper's knee among elite athletes from different sports. A cross-sectional study. Am. J. Sports Med. 33, 561-567 (Pubitemid 40411163)
5. Scott, A., Khan, K. M., and Duronio, V. (2005) IGF-I activates PKB and prevents anoxic apoptosis in Achilles tendon cells. J. Orthop. Res. 23, 1219-1225 (Pubitemid 41245451)
6. Ding, G. J., Fischer, P. A., Boltz, R. C., Schmidt, J. A., Colaianne, J. J., Gough, A., Rubin, R. A., and Miller, D. K. (1998) Characterization and quantitation of NF-κB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α. Development and use of a high capacity fluorescence cytometric system. J. Biol. Chem. 273, 28897-28905 (Pubitemid 28507582)
7. Tak, P. P., Gerlag, D. M., Aupperle, K. R., van de Geest, D. A., Overbeek, M., Bennett, B. L., Boyle, D. L., Manning, A. M., and Firestein, G. S. (2001) Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation. Arthritis Rheum. 44, 1897-1907 (Pubitemid 32758238)
8. Tang, J. B., Xu, Y., and Wang, X. T. (2004) Tendon healing in vitro. Activation of NIK, IKKα, IKKβ, and NF-κB genes in signal pathway and proliferation of tenocytes. Plast Reconstr. Surg. 113, 1703-1711 (Pubitemid 39201801)
9. Tsuzaki, M., Guyton, G., Garrett, W., Archambault, J. M., Herzog, W., Almekinders, L., Bynum, D., Yang, X., and Banes, A. J. (2003) IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J. Orthop. Res. 21, 256-264 (Pubitemid 36322545)
10. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., and Takada, Y. (2004) Role of resveratrol in prevention and therapy of cancer. Preclinical and clinical studies. Anticancer Res. 24, 2783-2840 (Pubitemid 39409568)
11. Shakibaei, M., Buhrmann, C., and Mobasheri, A. (2011) Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-κB ligand (RANKL) activation of NF-κB signaling and inhibit osteoclastogenesis in bone-derived cells. J. Biol. Chem. 286, 11492-11505
12. Shishodia, S., Chaturvedi, M. M., and Aggarwal, B. B. (2007) Role of curcumin in cancer therapy. Curr. Probl. Cancer 31, 243-305 (Pubitemid 47077491)
13. Das, S., and Das, D. K. (2007) Anti-inflammatory responses of resveratrol. Inflamm. Allergy Drug Targets 6, 168-173 (Pubitemid 47455785)
14. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220 (Pubitemid 127696281)
15. Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D., and Weinstein, I. B. (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8, 893-903 (Pubitemid 34742123)
16. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., Scherer, B., and Sinclair, D. A. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196 (Pubitemid 37150899)
17. Holmes-McNary, M., and Baldwin, A. S., Jr. (2000) Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res. 60, 3477-3483 (Pubitemid 30482167)
18. Manna, S. K., Mukhopadhyay, A., and Aggarwal, B. B. (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis. Potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164, 6509-6519 (Pubitemid 30408836)
19. Scherer, L. J., and Rossi, J. J. (2003) Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21, 1457-1465 (Pubitemid 37522705)
20. Pan, W. H., and Clawson, G. A. (2006) Antisense applications for biological control. J. Cell. Biochem. 98, 14-35
21. Pirollo, K. F., Rait, A., Sleer, L. S., and Chang, E. H. (2003) Antisense therapeutics. From theory to clinical practice. Pharmacol. Ther. 99, 55-77 (Pubitemid 36694750)
22. Boring, C. C., Squires, T. S., and Tong, T. (1991) Cancer statistics, 1991. CA Cancer J. Clin. 41, 19-36
23. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001) Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107, 137-148 (Pubitemid 33035941)
24. Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S. I., Frye, R. A., Pandita, T. K., Guarente, L., and Weinberg, R. A. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159 (Pubitemid 33035942)
25. Dinarello, C. A. (1997) Interleukin-1. Cytokine Growth Factor Rev. 8, 253-265
26. Chen, L. f., Fischle, W., Verdin, E., and Greene, W. C. (2001) Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293, 1653-1657 (Pubitemid 32807844)
27. Kiernan, R., Brès, V., Ng, R. W., Coudart, M. P., El Messaoudi, S., Sardet, C., Jin, D. Y., Emiliani, S., and Benkirane, M. (2003) Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278, 2758-2766 (Pubitemid 36801357)
28. Guarente, L., and Picard, F. (2005) Calorie restriction. The SIR2 connection. Cell 120, 473-482
29. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., and Mayo, M. W. (2004) Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380 (Pubitemid 38954844)
30. Ashburner, B. P., Westerheide, S. D., and Baldwin, A. S., Jr. (2001) The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21, 7065-7077 (Pubitemid 32916079)
31. Zhong, H., May, M. J., Jimi, E., and Ghosh, S. (2002) The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625-636 (Pubitemid 34273792)
32. Cao, Z., and Li, Y. (2004) Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes. Protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 489, 39-48 (Pubitemid 38520069)
33. Mizutani, K., Ikeda, K., Kawai, Y., and Yamori, Y. (1998) Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 253, 859-863 (Pubitemid 29039235)
34. Savouret, J. F., and Quesne, M. (2002) Resveratrol and cancer. A review. Biomed. Pharmacother 56, 84-87
35. Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., Bedalov, A., and Kennedy, B. K. (2005) Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 280, 17038-17045 (Pubitemid 41389166)
36. Ryan, K. M., Phillips, A. C., and Vousden, K. H. (2001) Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332-337 (Pubitemid 32429498)
37. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
38. Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-2841 (Pubitemid 28440142)
39. Gu, W., and Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606 (Pubitemid 27357952)
40. Haigis, M. C., and Guarente, L. P. (2006) Mammalian sirtuins. Emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913-2921 (Pubitemid 44771725)
41. Martínez-Balbás, M. A., Bauer, U. M., Nielsen, S. J., Brehm, A., and Kouzarides, T. (2000) Regulation of E2F1 activity by acetylation. EMBO J. 19, 662-671 (Pubitemid 30093739)
42. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
43. Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., and Green, D. R. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014 (Pubitemid 38209704)
44. Matsushita, N., Takami, Y., Kimura, M., Tachiiri, S., Ishiai, M., Nakayama, T., and Takata, M. (2005) Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells. Genes Cells 10, 321-332 (Pubitemid 40443684)
45. Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., and Sinclair, D. A. (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392 (Pubitemid 38938153)
46. Sakurai, H., Miyoshi, H., Toriumi, W., and Sugita, T. (1999) Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation. J. Biol. Chem. 274, 10641-10648
47. Gustin, J. A., Maehama, T., Dixon, J. E., and Donner, D. B. (2001) The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor κ B activity. J. Biol. Chem. 276, 27740-27744
48. Simeonidis, S., Stauber, D., Chen, G., Hendrickson, W. A., and Thanos, D. (1999) Mechanisms by which IκB proteins control NF-κB activity. Proc. Natl. Acad. Sci. U.S.A. 96, 49-54 (Pubitemid 29036051)
49. Schweitzer, R., Chyung, J. H., Murtaugh, L. C., Brent, A. E., Rosen, V., Olson, E. N., Lassar, A., and Tabin, C. J. (2001) Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 128, 3855-3866 (Pubitemid 32998933)
50. Shakibaei, M., and De Souza, P. (1997) Differentiation of mesenchymal limb bud cells to chondrocytes in alginate beads. Cell Biol. Int. 21, 75-86 (Pubitemid 27122416)
51. Shakibaei, M., John, T., Schulze-Tanzil, G., Lehmann, I., and Mobasheri, A. (2007) Suppression of NF-kB activation by curcumin leads to inhibition of expression of cyclooxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes. Implications for the treatment of osteoarthritis. Biochem. Pharmacol. 73, 1434-1445 (Pubitemid 46452591)
52. Shakibaei, M., John, T., De Souza, P., Rahmanzadeh, R., and Merker H. J. (1999) Signal transduction by ß1 integrin receptors in human chondrocytes in vitro: collaboration with IGF-I. Biochem. J. 342, 615-623 (Pubitemid 29452646)
53. Shakibaei, M., Csaki, C., Nebrich, S., and Mobasheri, A. (2008) Resveratrol suppresses interleukin-1β-induced inflammatory signaling and apoptosis in human articular chondrocytes. Potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem. Pharmacol. 76, 1426-1439
54. Csaki, C., Keshishzadeh, N., Fischer, K., and Shakibaei M (2008) Regulation of inflammation signaling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol, 75, 677-687
55. Chalk, A. M., and Sonnhammer, E. L. (2002) Computational antisense oligo prediction with a neural network model. Bioinformatics 18, 1567-1575 (Pubitemid 36097721)